The Journal of Organic Chemistry
Article
(35 mg, 0.1 mmol). The resultant mixture was stirred at room
temperature for 30 min before being filtered through a thin silica gel
pad eluting with EtOAc/hexane (1:1). The solvent was removed under
reduced pressure. The crude ketone was used in the next step without
further purification. A suspension of LiI (700 mg, 5.20 mmol), the
crude ketone (1.0 mmol), and phenyl acrylate (0.166 mL, 1.2 mmol)
in THF (5 mL) was placed in a 5 mL gastight syringe which was
mounted on a syringe drive. A small aliquot of the solution (0.5 mL)
was added to a mixture of Zn−Hg (1 g, 15 mmol) and SmI2 (0.1 M,
1.0 mL, 0.1 mmol) in THF (15 mL) at room temperature. The rest of
the solution was added by the drive over 9 h. The reaction mixture
changed color gradually from dark blue to light blue. A small portion
of TMSOTf (10 μL, 0.06 mmol) was then added via a 100 μL gastight
micro syringe as soon as the color of the reaction mixture faded to
light blue. The reaction mixture became dark blue again in less than 2
min. When the color faded to light blue, a second aliquot of TMSOTf
(10 μL, 0.06 mmol) was added to restore the dark blue color.
TMSOTf was added portionwise as described above until the reaction
was judged completed by TLC monitoring. The total amount of
TMSOTf used was about 550 μL (3.0 mmol), and the total time of
reaction was about 9 h. The reaction mixture was concentrated in
vacuo to remove THF, treated with saturated aqueous NaHCO3 (10
mL) and extracted with Et2O (3 × 10 mL). The combined organic
layers were washed with brine (1 mL), dried over anhydrous Na2SO4,
filtered, and concentrated under reduced pressure. The residue was
purified by flash chromatography on silica gel eluting with EtOAc/
hexane (2:1) to afford diastereomers 13a (194 mg, yield: 41%) and
13b (97 mg, yield: 20%).
1.05 (s, 9H), 1.31 (d, J = 7.1 Hz, 3H), 1.37−1.50 (m, 1H), 1.60 (dd, J
= 13.4, 10.8 Hz, 1H), 1.85 (ddd, J = 12.6, 6.3, 1.8 Hz, 1H), 1.99−2.13
(m, 3H), 2.20 (td, J = 12.6, 6.4 Hz, 1H), 2.32 (ddd, J = 18.2, 12.6, 6.2
Hz, 1H), 2.43−2.56 (m, 2H), 2.67−2.79 (m, 1H), 3.71 (dd, J = 10.1,
1.9 Hz, 1H), 3.81 (dd, J = 11.2, 4.8 Hz, 1H), 4.15 (dd, J = 10.1, 7.4 Hz,
1H), 4.15−4.20 (m, 1H), 7.34−7.44 (m, 6H), 7.58−7.62 (m, 4H); 13C
NMR (125 MHz, CDCl3) δ 16.7 (CH3), 19.3 (C), 24.4 (CH2), 26.9
(CH3), 27.3 (CH2), 28.7 (CH2), 34.6 (CH2), 35.0 (CH2), 35.3 (CH),
58.6 (CH), 63.4 (CH2), 64.9 (CH), 81.4 (C), 127.7 (CH), 129.8
(CH), 133.4 (C), 133.5 (C), 135.5 (CH), 135.6 (CH), 166.8 (CO),
178.0 (CO); HRMS (ESI) calcd for [C29H37NO4Si + Na+] 514.2384,
found 514.2388.
(2S,3′S,4R,8a′S)-3′-(Hydroxymethyl)-4-methyltetrahydro-
1′H,3H-spiro[furan-2,8′-indolizine]-5,5′(4H,8a′H)-dione (15).
To a cooled solution (0 °C) of compound 14 (41 mg, 0.08 mmol)
in anhydrous THF (1 mL) under N2 was added Py·HF (0.072 mL, 0.8
mmol) dropwise. After being stirred at room temperature for 24 h, the
mixture was concentrated under reduced pressure. The residue was
purified by flash chromatography on silica gel eluting with EtOAc/
MeOH (15:1) to afford compound 15 (18 mg, yield: 85%) as a white
20
solid: mp 156−158 °C (MeOH); [α]D −23.4 (c 0.5, CHCl3); IR
(film) νmax: 3407, 2917, 2849, 1767, 1620, 1452, 1382, 1215, 1070
cm−1; 1H NMR (500 MHz, CDCl3) δ 1.34 (d, J = 7.2 Hz, 3H), 1.41−
1.51 (m, 2H), 1.66 (dd, J = 13.5, 10.8 Hz, 1H), 1.93 (ddd, J = 12.5,
6.2, 1.6 Hz, 1H), 1.99−2.06 (m, 1H), 2.13−2.22 (m, 1H), 2.33 (td, J =
12.6, 6.2 Hz, 1H), 2.44 (ddd, J = 18.4, 12.6, 6.6 Hz, 1H), 2.51 (dd, J =
13.6, 9.9 Hz, 1H), 2.68−2.80 (m, 2H), 3.60 (dd, J = 11.4, 7.5 Hz, 1H),
3.72 (br, 1H), 3.76 (td, J = 11.4, 4.8 Hz, 1H), 4.18 (app q, J = 7.8 Hz,
1H); 13C NMR (125 MHz, CDCl3) δ 16.6 (CH3), 25.9 (CH2), 26.8
(CH2), 28.6 (CH2), 34.2 (CH2), 35.0 (CH2), 35.2 (CH), 62.4 (CH),
64.6 (CH), 66.9 (CH2), 81.0 (C), 169.7 (CO), 177.6 (CO); HRMS
(ESI) calcd for [C13H19NO4 + Na+]: 276.1206; found: 276.1211.
Synthesis of Compounds 17a and 17b by Swern Oxidation−
organozinc Reagent Addition. (2S,3′S,4R,8a′S)-4-Methyl-3′-
((S)-4-methylene-5-oxotetrahydrofuran-2-yl)tetrahydro-
1′H,3H-spiro[furan-2,8′-indolizine]-5,5′(4H,8a′H)-dione (17a)
and (2S,3′S,4R,8a′S)-4-Methyl-3′-((R)-4-methylene-5-oxotetra-
hydrofuran-2-yl)tetrahydro-1′H,3H-spiro[furan-2,8′-indoli-
zine]-5,5′(4H,8a′H)-dione (17b). To a cooled solution of (COCl)2
(0.09 mL, 0.96 mmol) in anhydrous CH2Cl2 (1 mL) was slowly added
DMSO (0.09 mL, 1.28 mmol) in anhydrous CH2Cl2 (1 mL) at −78
°C over 30 min. After being stirred at −78 °C for another 30 min, to
the reaction was slowly added compound 15 (80 mg, 0.32 mmol) in
anhydrous CH2Cl2 (2 mL) at −78 °C over 30 min. After being stirred
at −78 °C for an additional 1 h, to the solution was slowly added TEA
(0.25 mL, 1.92 mmol) at −78 °C over 30 min. After being stirred at
the same temperature for 2 h, the reaction was quenched with H2O (2
mL). The organic layer was separated, and the aqueous layer was
extracted with CH2Cl2 (3 × 2 mL). The combined organic layers were
washed with brine (1 mL), dried over anhydrous Na2SO4, filtered, and
concentrated under reduced pressure to afford crude compound 16 as
a pale yellow solid, which was used in the next step without further
purification. To a stirred solution of aldehyde 16 (79 mg, 0.32 mmol)
in dry THF (3 mL) under N2 atmosphere, Zn (83 mg, 1.28 mmol)
was added. The solution was heated, and when reflux started, a
solution of ethyl 2-(bromomethyl)acrylate (0.077 mL, 0.64 mmol) in
dry THF (1 mL) was added. After 1 h, TLC analysis of the reaction
mixture revealed the disappearance of the starting aldehyde. The
reaction mixture was filtered through Celite and the solvent was
evaporated under vacuum. The remaining colorless oil was purified by
preparative HPLC on reversed phase [separated by HPLC: Shim-pack
VP-ODS (150 × 15), CH3CN/H2O 75:25, 20 mL/min, λ = 254 nm, t1
= 13.4 min (41.2%), t2 = 15.6 min (58.8%)] to afford compound 17a
(38 mg, yield: 37%) and compound 17b (54 mg, yield: 53%).
Compound 17a: white solid; mp 188−190 °C (MeOH); [α]20D −74.0
(c 0.5, CHCl3); IR (film) νmax 2918, 1768, 1654, 1443, 1413, 1290,
Compound 13a: colorless oil; [α]20 −33.8 (c 1.0, CHCl3); IR
D
(film) νmax 3070, 3046, 2930, 2856, 1777, 1656, 1643, 1427, 1413,
1113, 1068, 1018 cm−1; 1H NMR (500 MHz, CDCl3) δ 1.06 (s, 9H),
1.41−1.53 (m, 1H), 1.88−2.04 (m, 3H), 2.05−2.21 (m, 4H), 2.33
(ddd, J = 18.5, 11.7, 6.8 Hz, 1H), 2.50−2.71 (m, 3H), 3.72 (dd, J =
10.2, 2.4 Hz, 1H), 3.86 (dd, J = 10.5, 5.2 Hz, 1H), 4.12 (dd, J = 10.2,
4.0 Hz, 1H), 4.18−4.26 (m, 1H), 7.34−7.44 (m, 6H), 7.58−7.61 (m,
4H); 13C NMR (125 MHz, CDCl3) δ 19.3 (C), 24.5 (CH2), 25.6
(CH2), 26.8 (CH2), 26.9 (CH3), 28.6 (CH2), 28.8 (CH2), 33.2 (CH2),
58.7 (CH), 63.6 (CH2), 64.6 (CH), 83.7 (C), 127.7 (CH), 129.8
(CH), 133.3 (C), 133.4 (C), 135.5 (CH), 135.6 (CH), 166.8 (CO),
175.2 (CO); HRMS (ESI) calcd for [C28H35NO4Si + Na+] 500.2228,
found 500.2234.
Compound 13b: colorless oil; [α]20 −62.8 (c 1.0, CHCl3); IR
D
(film) νmax 3070, 3044, 2955, 2930, 2857, 1779, 1641, 1461, 1427,
1411, 1193, 1112, 1028 cm−1; 1H NMR (500 MHz, CDCl3) δ 1.06 (s,
9H), 1.72 (m, 1H), 1.83 (m, 1H), 1.91−1.98 (m, 1H), 2.00−2.11 (m,
4H), 2.12−2.18 (m, 1H), 2.37 (dd, J = 17.3, 6.2 Hz, 1H), 2.48−2.72
(m, 3H), 3.66 (dd, J = 11.0, 5.4 Hz, 1H), 3.76 (dd, J = 10.2, 2.3 Hz,
1H), 4.16 (dd, J = 10.2, 3.9 Hz, 1H), 4.24−4.30 (m, 1H), 7.34−7.44
(m, 6H), 7.59−7.62 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 19.4
(C), 23.9 (CH2), 25.5 (CH2), 26.9 (CH3), 28.0 (CH2), 28.2 (CH2),
30.1 (CH2), 32.9 (CH2), 58.3 (CH), 64.3 (CH2), 65.8 (CH), 81.7
(C), 127.68 (CH), 127.70 (CH), 129.7 (CH), 129.8 (CH), 133.5 (C),
133.6 (C), 135.49 (CH), 135.53 (CH), 167.1 (CO), 175.6 (CO);
HRMS (ESI) calcd for [C28H35NO4Si + Na+] 500.2228, found
500.2228.
(2S,3″S,4R,8a′S)-3′-((tert-Butyldiphenylsilyloxy)methyl)-4-
methyltetrahydro-1′H,3H-spiro[furan-2,8′-indolizine]-
5,5′(4H,8a′H)-dione (14). To a solution of lactone 13a (400 mg,
0.84 mmol) in THF (8.5 mL) was added LiHMDS (0.872 mL, 0.924
mmol, 1.06 M in THF/ethylbenzene) at −78 °C under N2. After the
solution was stirred at −78 °C for 30 min, MeI (0.26 mL, 4.20 mmol)
was added and stirring continued for 1 h at −78 °C. The reaction was
quenched with saturated NH4Cl (0.5 mL), and the resulting mixture
was extracted with EtOAc (3 × 10 mL). The combined organic layers
were dried over anhydrous Na2SO4, filtered, and concentrated under
reduced pressure. The residue was purified by flash chromatography
on silica gel eluting with EtOAc to afford compound 17 (296 mg,
yield: 72%) as a white solid: mp 78−81 °C (EtOAc); [α]20D −35.0 (c
0.9, CHCl3); IR (film) νmax 3075, 3041, 2917, 2849, 1777, 1657, 1642,
1
1254, 1116, 1019 cm−1; H NMR (500 MHz, CDCl3) δ 1.32 (d, J =
7.2 Hz, 3H), 1.44−1.54 (m, 1H), 1.63 (dd, J = 13.6, 10.1 Hz, 1H),
1.78−1.86 (m, 1H), 1.88 (ddd, J = 18.0, 6.4, 3.5 Hz, 1H), 2.06−2.16
(m, 2H), 2.20 (ddd, J = 18.0, 13.0, 6.5 Hz, 1H), 2.36 (ddd, J = 18.4,
1
1427, 1383, 1284, 1113, 1019 cm−1; H NMR (500 MHz, CDCl3) δ
E
dx.doi.org/10.1021/jo3014484 | J. Org. Chem. XXXX, XXX, XXX−XXX